Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Aromatherapie beim vollständigen Knieersatz

29. Oktober 2026 aktualisiert von: Hospital for Special Surgery, New York

Aromatherapy for Post-operative Anxiety and Pain After Primary Unilateral Total Knee Replacement: A Pilot Randomized Controlled Trial

The purpose of this pilot randomized controlled trial is to investigate the effects of aromatherapy on postoperative anxiety and pain in total knee replacement patients. The primary research questions are:

Does Lavender-Peppermint Aromatherapy reduce post operative anxiety in patients after primary total knee replacement when compared to placebo?

Does Lavender-Peppermint Aromatherapy reduce post operative pain in patient after primary total knee replacement when compared to placebo?

Participants will be assigned to one of the following groups at random:

  • Intervention: Aromatherapy with the lavender-peppermint scent
  • Control: Aromatherapy with the almond oil scent

Participants will also be asked to complete pre- and post-operative questionnaires.

Researchers will compare both groups (intervention vs control) to see if aromatherapy reduces post-operative anxiety and/or pain.

Studienübersicht

Detaillierte Beschreibung

Preoperative depression, anxiety, and catastrophizing have all been linked to an increase in postoperative pain and opiate use. Although aromatherapy, specifically lavender, may lower anxiety, no placebo-controlled trial has been undertaken to establish Aromatherapy's therapeutic promise for anxiety after total knee replacement. Although peppermint has been demonstrated to reduce nausea and vomiting, it has not been tested in this population for post-operative nausea and vomiting (PONV). The purpose of this pilot randomized controlled study is to determine the effectiveness of Lavender-Peppermint in reducing post-operative anxiety and discomfort in patients following unilateral primary knee replacement surgery.

The primary research questions are:

Does Lavender-Peppermint Aromatherapy reduce post operative anxiety in patients after primary total knee replacement when compared to placebo?

Does Lavender-Peppermint Aromatherapy reduce post operative pain in patient after primary total knee replacement when compared to placebo?

Participants will be assigned to one of the following groups at random:

  • Intervention: Aromatherapy in the lavender-peppermint scent
  • Control: Aromatherapy in the almond oil scent

Participants will also be asked to complete pre- and post-operative questionnaires via the following surveys/questionnaires:

  • State-Trait Anxiety Inventory Short Form
  • PROMIS Anxiety v1.0 (short form 8a)
  • PROMIS Depression v1.0 (short form 8a)
  • PROMIS Pain Interference v1.1 (short form 6b)
  • Pain Catastrophizing Scale
  • Pain Rating Scale in Numeric Form
  • Opioid Consumption
  • Opioid Related Symptoms Distress Scale
  • Adverse Events
  • Aromatherapy Satisfaction Questionnaire
  • Bang Blinding Index

Researchers will compare both groups (intervention vs control) to see if aromatherapy reduces post-operative anxiety and/or pain.

Studientyp

Interventionell

Einschreibung (Tatsächlich)

30

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

    • New York
      • New York, New York, Vereinigte Staaten, 10021
        • Hospital for Special Surgery

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre bis 80 Jahre (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • Age > 18 and ≤ 80
  • Scheduled to undergo primary, unilateral knee replacement surgery
  • Willing and able to provide informed consent
  • Willing and able to complete follow-up procedures
  • Intact olfactory function
  • Score 19 or greater on the PROMIS Anxiety Shortform 8A

Exclusion Criteria:

  • Score <19 on the PROMIS Emotional Distress - Anxiety - Short Form 8a
  • Current major anxiety or depression
  • Currently taking medications to treat anxiety
  • Impaired sense of smell
  • History of chronic pain with opioid use for greater than 3 months
  • History of Drug or Alcohol abuse
  • History of fibromyalgia
  • History of G6PD deficiency
  • Plant or tree nut allergy
  • Severe allergy to Opioids, NSAIDS or local anesthetics (such as anaphylaxis)
  • Severe liver disease, renal insufficiency (with inability to take acetaminophen or NSAIDS)
  • Non-English Speaking
  • Surgery requiring a hospitalization of greater than 3 days
  • Patient refusal
  • Current cardiac fibrillation
  • Chronic opioid user (>3 months)
  • BMI ≥ 45
  • Contraindication to neuraxial anesthesia

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Sonstiges
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Doppelt

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Lavender-Peppermint Aromatherapy Group

This is the interventional group. Participants in this group will receive aromatherapy tabs in the scent of lavender-peppermint. Tabs will be worn on a badge for a total of 72 hours, and participants will replace the aroma tabs every 12 hours.

100% pure essential oils Lavender-peppermint aromatabs purchased through Beekley Medical

Placebo-Komparator: Almond-oil Aromatherapy Group

This is the placebo group. Participants in this group will receive aromatherapy tabs in the scent of almond oil. Tabs will worn on a badge for a total of 72 hours, and participants will replace the aroma tabs every 12 hours.

100% pure essential oils Almond-oil aromatabs purchased through Beekley Medical

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
State Trait Anxiety Inventory
Zeitfenster: Measured pre-operatively, in the post-anesthesia care unit (PACU), post-operative day (POD) 1, POD 2, POD 3, POD 7

To assess the change in participants' anxiety level before and each individual day after surgery. Measured using the State-Trait Anxiety Inventory (STAI).

STATE anxiety, with higher scores being worse:

For calm, at ease, relaxed, steady:

4 = not at all 3 = somewhat 2 = moderately so

1 = very much so

For tense, worrying over misfortunes, frightened, nervous, jittery, worried:

  1. = not at all
  2. = somewhat
  3. = moderately so
  4. = very much so

TRAIT anxiety, with higher scores being worse:

For self satisfaction, feeling secure, being steady:

4=almost never 3=sometimes 2=often

1=almost always

For nervous/restless, wishing to be happier, feeling like a failure, worrying too much, lacking self confidence, feeling inadequate, feeling tension:

  1. almost never
  2. sometimes
  3. often
  4. almost always

STAI is scored as a sum of the scores for state and trait, with 20 being the lowest score (better outcome) and 80 being the highest score (worse outcome).

Measured pre-operatively, in the post-anesthesia care unit (PACU), post-operative day (POD) 1, POD 2, POD 3, POD 7
Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety Short Form 8a Version 1.0
Zeitfenster: Measured pre-operatively and on post-operative day (POD) 7

To assess participants' preoperative (cumulative 7 days before surgery) and postoperative (cumulative 7 days after surgery) anxiety. Measured using the PROMIS anxiety short form 8a Version 1.0. Scored on the following scale:

  1. = never
  2. = rarely
  3. = sometimes
  4. = often
  5. = always with 1 being the lowest score and 5 being the highest scores.

PROMIS anxiety short form 8a Version 1.0 is scored by calculating the sum of the scores for each question, and using the PROMIS conversion matrix to report the T-score (The T-score is a standardized metric where the United States general population mean is set to 50 with a standard deviation (SD) of 10. Higher T-scores indicate greater levels of anxiety.)

Measured pre-operatively and on post-operative day (POD) 7
Numeric Rating Scale Pain Scores
Zeitfenster: Measured pre-operatively, in the post-anesthesia care unit (PACU), post-operative day (POD) 1, POD 2, POD 3, POD 7

To assess the average pain score of participants after surgery. Measured using the numerical rating scale (NRS). Measured on a 11-point numeric scale from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable").

Measured pre-operatively, in the post-anesthesia care unit (PACU), post-operative day (POD) 1, POD 2, POD 3, POD 7

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Patient-Reported Outcomes Measurement Information System (PROMIS) Depression Short Form 8a
Zeitfenster: Measured pre-operatively and on post-operative day (POD) 7

To assess participants' post-operative emotional distress. Measured using the PROMIS depression short form 8a. Scored on the following scale:

  1. = never
  2. = rarely
  3. = sometimes
  4. = often
  5. = always with 1 being the lowest score and 5 being the highest scores.

Scored by calculating the sum of the scores for each question, and using the PROMIS conversion matrix to report the T-score. (The T-score is a standardized metric where the United States general population mean is set to 50 with a standard deviation (SD) of 10. Higher T-scores indicate greater levels of anxiety.)

Measured pre-operatively and on post-operative day (POD) 7
Pain Catastrophizing Scale
Zeitfenster: Measured pre-operatively, post-operative day (POD) 1, POD 2, POD 3, POD 7

The Pain Catastrophizing Scale is made up of 13 phrases that describe various thoughts and sensations that people may have while they are in pain. The items are assessed on a 5-point scale and are grouped into three categories: rumination (4 questions), magnification (3 questions), and helplessness (6 questions). Scored on the following scale:

0 = Not at all

  1. = To a slight degree
  2. = To a moderate degree
  3. = To a great degree
  4. = All the time with 0 being the lowest and 4 being the highest score.

Scored as the sum of all questions, and the sum of the scores for each question within each subscale. The range for Total Sum: 0 to 52, Rumination: 0 to 16, Magnification: 0 to 12, Helplessness: 0 to 24

Measured pre-operatively, post-operative day (POD) 1, POD 2, POD 3, POD 7
Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v1.1 Pain Interference
Zeitfenster: Measured pre-operatively and on post-operative day (POD) 7

The PROMIS SF v1.1 Pain Interference instruments (adult) measure the self-reported consequences of pain on relevant aspects of a person's life and may include the extent to which pain hinders engagement with social, cognitive, emotional, physical, and recreational activities. Pain Interference also incorporates items probing sleep and enjoyment in life, though the item bank only contains one sleep item. The Pain Interference items utilize a 7-day recall period (items include the phrase "the past 7 days"). Scored on the following scale:

  1. = Not at all
  2. = A little bit
  3. = Somewhat
  4. = Quite a bit
  5. = Very much With 1 being the lowest and 5 being the highest

Scored by calculating the sum of the scores for each question, and using the PROMIS conversion matrix to report the T-score. (The T-score is a standardized metric where the United States general population mean is set to 50 with a standard deviation (SD) of 10. Higher T-scores indicate greater levels of anxiety.)

Measured pre-operatively and on post-operative day (POD) 7
Post-operative Opioid Consumption
Zeitfenster: Measured in the post-operative care unit (PACU), post-operative day (POD) 1, POD2, POD3, POD7

Self-reported measure of medication, dosage, and time of opioid consumption. Reported as Morphine Milligram equivalents.

Measured in the post-operative care unit (PACU), post-operative day (POD) 1, POD2, POD3, POD7
Number of Participants With Post-operative Nausea
Zeitfenster: Measured at post-anesthesia care unit (PACU), post-operative day (POD) 1, POD 2, POD 3, POD 7

To assess if participants experience post-operative nausea. Measured using the Opioid Related Symptom Distress Scale question: In the past 24 hours, I had nausea (yes/no).

Measured at post-anesthesia care unit (PACU), post-operative day (POD) 1, POD 2, POD 3, POD 7
Number of Participants With Post-operative Vomiting
Zeitfenster: Measured at post-anesthesia care unit (PACU), post-operative day (POD) 1, POD 2, POD 3, POD 7

To assess if participants experience post-operative vomiting. Measured using the Opioid Related Symptom Distress Scale question: In the past 24 hours, I had vomiting (yes/no).

Measured at post-anesthesia care unit (PACU), post-operative day (POD) 1, POD 2, POD 3, POD 7
Incidences of Post-operative Complications
Zeitfenster: Measured at post-anesthesia care unit (PACU) up to post operative day 7

To assess the incidences of post-operative complications such as need for ICU admission, DVT/PE, MI, stroke.

To be measured in the number of patients who reported adverse events.

Measured at post-anesthesia care unit (PACU) up to post operative day 7
Opioid-related Symptom Distress Scale
Zeitfenster: Measured at post-anesthesia care unit (PACU), post-operative day (POD) 1, POD 2, POD 3, POD 7

The Opioid-Related Symptom Distress Scale (ORSDS) assesses opioid-related symptoms across the dimensions of frequency, severity, and bothersomeness. According to the scoring manual, Clinically Meaningful Events (CMEs) are calculated using the symptom severity items only. Severity is rated on a 5-point scale ranging from 0 (did not have symptom) to 4 (very severe). Therefore, scores range from 0 to 4, with higher scores indicating greater symptom severity.

Measured at post-anesthesia care unit (PACU), post-operative day (POD) 1, POD 2, POD 3, POD 7
Participants' Satisfaction With the Aromatherapy
Zeitfenster: Measured at post operative day 7

Self-reported responses on a survey of 7-items to assess participants' level of satisfaction with the aromatherapy they received.

Measured on the following scales:

  1. = Not satisfied/no prior knowledge or experience/ not at all/ no
  2. = A little bit/a little knowledge or experience/to a slight degree
  3. = Moderately/moderate knowledge or experience/to a moderate degree
  4. = Quite a bit/considerable knowledge or experience/to a great degree
  5. = Extremely satisfied/expert knowledge or regular application/all of the time/ yes with 1 being the lowest and 5 being the highest.
Measured at post operative day 7
Aromatab Adherence
Zeitfenster: Measured on post operative day (POD) 1, POD2, POD3.

Feasibility was assessed as the number of Participants that reported "Yes" to wearing each aromatab.

Measured on post operative day (POD) 1, POD2, POD3.
Hospital Length of Stay
Zeitfenster: Measured at discharge as number of hours elapsed between post anesthesia care unit entry and discharge time

Hospital length of stay was measured as hours elapsed from post anesthesia care unit entry to discharge, assessed up to 7 days.

Measured at discharge as number of hours elapsed between post anesthesia care unit entry and discharge time
Bang Blinding Index
Zeitfenster: Measured on postoperative day 7

The Bang Blinding Index ranges from -1 to 1, where index of 0 indicates random guessing (perfect blinding, better outcome), 1 indicates complete unblinding (all guesses are correct, worse outcome), and -1 indicates complete opposite guessing (all guesses are incorrect, worse outcome). Patients were asked to guess whether the patient was given the intervention (Lavender-Peppermint) or Control (Almond Oil) Aromatherapy. For each arm, calculation of the index score involves subtracting the proportion of respondents assigned to that arm who guess incorrectly from the proportion that guessed correctly.

Measured on postoperative day 7

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Hauptermittler: Uchenna Umeh, MD, Hospital for Special Surgery, New York

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Allgemeine Veröffentlichungen

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

3. Oktober 2023

Primärer Abschluss (Tatsächlich)

1. April 2024

Studienabschluss (Tatsächlich)

1. April 2024

Studienanmeldedaten

Zuerst eingereicht

13. September 2023

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

13. September 2023

Zuerst gepostet (Tatsächlich)

21. September 2023

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

3. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

29. Oktober 2026

Zuletzt verifiziert

1. Januar 2025

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Beschreibung des IPD-Plans

There is no plan to make IPD available to other researchers.

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren